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eativecommons.org/licenses/by-nc-Summary Esophageal cancer is a common and highly lethal disease. In the Asia-Pacific re-
gion, esophageal squamous cell neoplasias are the major forms of the disease. Recent ad-
vances in endoscopic therapy enable curative treatment of early esophageal squamous cell
neoplasias, however, the technique is complicated and requires a high level of expertise, espe-
cially for those with long-segment lesions. Endoscopic radiofrequency ablation is a rapidly
evolving treatment modality and has been shown to have good efficacy and safety for the
treatment of dysplasia in cases of Barrett’s esophagus. Theoretically, it can also be used to
treat squamous dysplasia. We report a case of a 48-year-old man with an 8-cm-long circumfer-
ential squamous high-grade dysplasia over the esophagus (from 21 cm to 29 cm below the
incisor) that was treated successfully and safely with balloon-based radiofrequency ablation.
The procedure took only around 30 minutes to complete. There were no major adverse events
during and after the procedure. In addition, we examined the histology of the esophageal co-
agulum, which showed an extensive cauterization effect with focal dysplasia within the abla-
ted epithelium. Follow-up endoscopy at 1 month, 3 months, and 6 months showed no residual
lesion, and biopsies also confirmed complete remission.
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Esophageal cancer is a highly lethal disease, causing
>400,000 deaths/y worldwide [1]. It ranks as the sixth most
common cause of cancer death, and >70% of esophageal
cancer cases occur in Asia [1]. In the Asia-Pacific region,
esophageal squamous cell neoplasia (ESCN) is the major
histological type of the disease [2]. Recent advances in
image-enhanced endoscopy enable accurate diagnosis of
early-stage ESCNs [3]. Endoscopic treatment serves as an
excellent option with curative intent, because lesions of
squamous high-grade dysplasia or carcinomas are limited to
the epithelium or lamina propria with little risk of lymph
node metastasis [4]. Recently, endoscopic submucosal
dissection (ESD) is gaining attention as a treatment tool [4].
However, in order to acquire the necessary skill-set for
good and safe application of ESD techniques, a significant
learning curve is required [5]. Due to this limitation, this
technique cannot be expanded worldwide and can only be
carried out in some high-volume centers. In addition,
esophageal stenosis is still a great concern, especially for
long-segment lesions or lesions covering more than three-
quarters of the circumference of the esophagus [6].
Endoscopic radiofrequency ablation (RFA) is a rapidly
evolving treatment modality, and has been shown to have
good efficacy and safety for the treatment of dysplasia in
cases of Barrett’s esophagus (BE) [7]. Theoretically, it can
also be used to treat squamous dysplasia, however, previ-
ous reports are very rare [8,9]. We report a case with an 8-
cm-long circumferential squamous high-grade dysplasia
over the esophagus (from 21 cm to 29 cm below the incisor)
that was treated successfully and safely with balloon-based
RFA.
Case Report
A 48-year-old man with a social history significant for
alcohol consumption, smoking, and betel nut chewing for
several decades was referred for an esophagogas-
troduodenoscopic examination due to his acid regurgita-
tion symptoms. Conventional white-light endoscopy
showed a faint circumferential flat hyperemic lesion over
the upper esophagus. Lugol chromoendoscopy showed an
8-cm-long well-demarcated Lugol-voiding lesion, occu-
pying almost the total circumference of the esophagus
from 21 cm to 29 cm below the incisor (Figures 1AeC).
Narrow-band imaging with magnification showed dilated
intraepithelial papillary capillary loops, which are consis-
tent with high-grade intraepithelial neoplasia. The his-
tology taken from endoscopic biopsy every 2 cm confirmed
a high-grade squamous dysplasia (Figure 1D). Subsequent
endoscopic ultrasound and computer topography scan
showed that there was no lymphadenopathy or distant
metastasis. After detailed explanations of the use of RFA
or ESD and alternative treatment options, the patient
agreed to be treated with balloon-type RFA and provided
informed consent. The HALO360 System (Covidien GI So-
lutions, Sunnyvale, CA, USA), which consists of an ablation
catheter, an energy generator, and a sizing balloon, was
deployed for the eradication of the esophageal lesion. The
procedure was performed under general anesthesia. Lugolstaining was performed before RFA to determine the
location and extent of the Lugol-voiding lesions. Then, a
sizing balloon was introduced over a guide-wire to mea-
sure the inner diameter of the esophagus. Accordingly, an
18-mm-diameter balloon catheter with a 3-cm-long bipolar
array that can deliver short-burst (1 second) RFA at 40 W/
cm2 and 12 J/cm2 was selected and introduced over the
guide-wire to the diseased segment. We used a 12 J/
cm2ecleane12 J/cm2 regimen [8] for the procedure
(Figures 1EeG). The treatment area included 1 cm prox-
imal to 1 cm distal of the Lugol-voiding lesion. We started
ablation from the oral to the distal side with a 0.5-cm
overlap between each application. After electrode acti-
vation, the energy generator sensed and reported good
efficacy over the treatment area in all applications. After
the first pass of ablation, an endoscope equipped with a
transparent cap was used to remove adherent coagulum
from the ablation zone. Then, the ablation catheter was
reintroduced and the area was treated for a second time.
The procedure time was only approximately 30 minutes.
No immediate adverse events were noted (Figure 1G). The
removed coagulum was sent for a histological examina-
tion, and it showed an extensive cauterization effect with
focal dysplastic epithelium (Figures 1H and 1I). After the
procedure, the patient was provided with esomeprazole
40 mg/d and sucralfate suspension 5 mL (200 mg/mL) four
times daily for 1 month. He started oral intake on Day 2
post-RFA. Chest pain and throat pain developed after the
procedure and resolved within 3 days. He was discharged
uneventfully on the 3rd day post-RFA. Follow-up endoscopy
at 1 month, 3 months, and 6 months showed no residual
Lugol-voiding lesion or stricture (Figures 1JeL). Biopsies
taken randomly from the normal-appearing mucosa every
2 cm over the treatment area also confirmed a complete
remission.Discussion
The incidence of esophageal cancer is increasing rapidly in
Taiwan [2]. Recent advances in endoscopic techniques have
led to an earlier diagnosis of esophageal squamous mucosal
cancer or precancerous lesions, which can be cured by ESD
[3,4]. However, ESD not only requires considerable exper-
tise, but may also lead to esophageal strictures in larger
lesions [6]. Thus, a more convenient and safe method is
desired. We report a case with long-segment circumfer-
ential squamous high-grade dysplasia that was treated
successfully and safely using balloon-based RFA. The RFA
procedure does not require a high level of endoscopic
expertise, and is a potentially safe and effective procedure
to treat early ESCNs. Interestingly, we, for the first time,
demonstrated the histology of esophageal coagulum that
showed an extensive cauterization effect (Figures 1H
and 1I).
Although ESD is gaining increasing attention, it remains a
challenging technique, and is both time consuming and
associated with a higher rate of complications (including
perforation, massive bleeding, and postprocedural stric-
tures) [4]. The incidence of these complications is strongly
related to the size and depth of invasion of the lesion, and
the excision extension of the lumen [6]. Safe and
Figure 1 Endoscopic images prior to, during, and after balloon-based radiofrequency ablation of a long-segment circumferential
high-grade dysplasia. (A) A reddish, rough-appearing, and circumferential lesion with conventional white-light imaging. (B, C) Lugol
chromoendoscopy showing a well-demarcated long-segment unstained lesion. (D) Endoscopic biopsy showing squamous high-grade
dysplasia. (E) Treatment with the first balloon-based RFA. (F) After the first ablation pass, a circumferentially ablated segment was
seen. (G) After the removal of coagulum and the second ablation pass, a circumferentially ablated segment with good ablation
effect was seen. (H) The histology of retracted coagulum showed an extensive cauterization effect. (I) High-power view of the
coagulum revealed focal dysplasia within the ablated epithelium. (JeL) Three months after treatment, a normal-appearing
squamous esophagus was seen on conventional white-light imaging and no unstained lesions were seen after Lugol staining.
RFA Z radiofrequency ablation.
RFA for early esophageal squamous neoplasia 189satisfactory performance of ESD involves a significant
learning curve [5]. This has limited the use of ESD to some
high-volume centers, with limited expansion worldwide.
However, RFA appears to be less technically demanding,
with a smaller learning curve compared to ESD. RFA has the
potential to be more widespread due to being technically
simpler for endoscopists to perform. RFA is already the first
choice of treatment for dysplasia in cases of BE in many
countries [7]. Particularly, in our experience, ablation of
squamous neoplasia is technically easier than that of BE
primarily due to two reasons: (1) squamous epithelium
sloughs more readily than BE mucosa; and (2) BE always
involves the esophagocardial junction, making endoscopic
contact more challenging.
Previous studies related to RFA for treating early ESCNs,
especially long-segment ESCNs, are rare [8,9]. When mak-
ing decisions regarding the choice of endoscopic treatment,
one must consider additional merits of each technique.
Complete ESD has the advantage of providing the whole
resected specimens for histologic evaluation. RFA is a
tissue-destructive treatment modality and does not allow
pathology to be examined for evaluating curability after
ablation. This is the major concern of RFA and thus it should
be used to treat esophageal squamous cancer conserva-
tively. It is still unclear what the actual depth of ablation is
using RFA for squamous neoplasia. Only one previous study
reported the ablation depth in humans over the normalsquamous epithelium [3 of 5 patients achieved histological
ablation depth to the muscularis mucosa (m3) layer with 2
ablations of 12 J/cm2 regimen] [10]. A recent study from
the UK registry demonstrated that 30% of patients with
early squamous cell neoplasias progressed to invasive can-
cers after only one ablation at each treatment session [9].
Therefore, the treatment using RFA with a 12-J/
cm2ecleane12J/cm2 regimen, like in our case, may be
effective and indicated for m1 (intraepithelial neoplasia) or
m2 (lamina propria invasion) ESCNs. In our opinion, RFA is
justified only for truly flat lesions after detailed endoscopic
inspections to exclude signs of submucosal invasions.
Furthermore, we should keep in mind that the risks of
incomplete ablation and recurrences of ESCNs after treat-
ment dictate the need for strict patient selection and
continuing endoscopic surveillance. Despite the fact that
there was no residual dysplasia or local recurrence in this
case during the follow-up period, biopsy specimens from
the treatment area even with normal Lugol staining might
be insufficient to exclude the presence of “buried” squa-
mous neoplasia. A longer-term follow up is needed to
clarify this issue.
In summary, we demonstrated that RFA has the potential
to become an easier and effective technique for treating
large early ESCNs. It does not require a high level of
endoscopic expertise and is also associated with fewer
adverse events.
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